SCHEMBL5705409

SCHEMBL5705409

CCOC(=O)C(C)CCCCC(=O)CCCC[C@](C)(C(=O)OCC)c1ccc(CC(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.34
PPARG P37231 2/20 0.34
TRPV1 Q8NER1 2/20 0.32
PTGS2 P35354 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3280416 0.92 PTGS2 (0.36) TRPV1PTGS2
SCHEMBL6205871 0.82 TRPV1 (0.34) EPHX2PPARGTRPV1PTGS2
SCHEMBL3285614 0.81 TRPV1 (0.36) EPHX2PPARGTRPV1PTGS2
SCHEMBL7152528 0.79 PTGS1 (0.39) TRPV1PTGS2
SCHEMBL3280166 0.78 CYP4F2 (0.39)
SCHEMBL31103468 0.78 PTGS2 (0.42) PTGS2
SCHEMBL3286264 0.77 PTGS1 (0.42) TRPV1PTGS2
SCHEMBL3279141 0.76 FAAH (0.40) TRPV1PTGS2
SCHEMBL3280424 0.76 PTGS2 (0.33) TRPV1PTGS2
SCHEMBL3279889 0.76 PIN1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1701931-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics, Inc. (US) 2006-09-20 EP disclosed
WO-2005068412-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 WO disclosed
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP disclosed
WO-2002030860-A9 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS INC (US) 2003-02-20 WO disclosed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO disclosed